Drug:
Reaction: ERYTHEMA
20260101 - 20261231
No. 101 - 200
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 101 | 26939191 |
US |
2 | |
Paraesthesia, Erythema, |
||||
ABALOPARATIDE, |
||||
| 102 | 26939385 |
US |
64 | 2 |
Erythema, Nausea, |
||||
ABALOPARATIDE, ABALOPARATIDE, PHYTONADIONE, MAGNESIUM, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, AMOXICILLIN, ERGOCALCIFEROL, |
||||
| 103 | 26939592 |
US |
2 | |
Blood uric acid increased, Joint swelling, Erythema, Arthralgia, Photopsia, |
||||
ABALOPARATIDE, |
||||
| 104 | 26939603 |
US |
2 | |
Erythema, Skin burning sensation, Headache, Rash, Hypersensitivity, |
||||
ABALOPARATIDE, ROMOSOZUMAB-AQQG, DUTASTERIDE, SPIRONOLACTONE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, |
||||
| 105 | 26939740 |
US |
2 | |
Erythema, Skin burning sensation, Condition aggravated, Skin disorder, Pruritus, |
||||
ABALOPARATIDE, RISANKIZUMAB-RZAA, |
||||
| 106 | 26939839 |
US |
2 | |
Lymphadenopathy, Swelling face, Pollakiuria, Erythema, Urticaria, Abdominal distension, Dizziness, Drug hypersensitivity, Headache, Pain, Rash, Abdominal pain upper, Pruritus, Nausea, Malaise, Off label use, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, AZITHROMYCIN MONOHYDRATE, ERGOCALCIFEROL, ESTRADIOL, MONTELUKAST SODIUM, MONTELUKAST SODIUM, MONTELUKAST, TERIPARATIDE, VITAMIN C, LINACLOTIDE, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, MAGNESIUM, ERGOCALCIFEROL, BIOTIN, LEVOTHYROXINE SODIUM, DIPHENHYDRAMINE HYDROCHLORIDE, |
||||
| 107 | 26939841 |
US |
2 | |
Flushing, Erythema, |
||||
ABALOPARATIDE, |
||||
| 108 | 26940030 |
JP |
2 | |
Bacillus bacteraemia, Gastroenteritis, Pyrexia, Chills, Diarrhoea, Feeding disorder, Craniosynostosis, Milk allergy, Staphylococcal abscess, Skin hypertrophy, Papule, Erythema, Hyperkinesia, Restlessness, Off label use, |
||||
FLUCONAZOLE, |
||||
| 109 | 26942946 |
71 | 2 | |
Rash, Infusion related reaction, Erythema, |
||||
OCRELIZUMAB, |
||||
| 110 | 26943362 |
2 | ||
Erythema, Dyspnoea, Central nervous system lesion, Therapy interrupted, |
||||
GLATIRAMER ACETATE, DIROXIMEL FUMARATE, DIMETHYL FUMARATE, OFATUMUMAB, OXYCODONE, |
||||
| 111 | 26931178 |
CA |
60 | 1 |
Pseudomonas infection, COVID-19, Asthma, Tachycardia, Erythema, Obstructive airways disorder, Sputum discoloured, Sputum increased, |
||||
DUPILUMAB, DUPILUMAB, TIOTROPIUM BROMIDE, MONTELUKAST SODIUM, ALBUTEROL SULFATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CLOPIDOGREL, CLOPIDOGREL BISULFATE, ROSUVASTATIN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, DENOSUMAB, CLOPIDOGREL, |
||||
| 112 | 26931337 |
US |
1 | |
Pruritus, Malnutrition, Stress, Erythema, |
||||
BIMEKIZUMAB, |
||||
| 113 | 26931615 |
EU |
78 | 2 |
Erythema, Pharyngeal oedema, |
||||
ALLOPURINOL, ALLOPURINOL, ALLOPURINOL, ALLOPURINOL, IMATINIB, IMATINIB, IMATINIB, IMATINIB, |
||||
| 114 | 26931628 |
US |
1 | |
Erythema, Dermatitis, Eczema, Dry skin, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 115 | 26931649 |
US |
2 | |
Erythema, |
||||
DUPILUMAB, |
||||
| 116 | 26931678 |
US |
2 | |
Neck pain, Pain, Emotional distress, Pyrexia, Erythema, Abdominal pain upper, Dyspepsia, Diarrhoea, Dehydration, Vomiting, |
||||
TIRZEPATIDE, |
||||
| 117 | 26931761 |
US |
3 | 1 |
Pruritus, Erythema, |
||||
DUPILUMAB, |
||||
| 118 | 26931773 |
EU |
42 | 2 |
Hypersensitivity, Erythema, |
||||
RITUXIMAB, |
||||
| 119 | 26931788 |
US |
2 | |
Rash pruritic, Arthralgia, Headache, Erythema, Pain in extremity, Musculoskeletal discomfort, |
||||
DUPILUMAB, AMLODIPINE BESYLATE, ATENOLOL, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, BENAZEPRIL HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, BUSPIRONE HYDROCHLORIDE, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, FLUOXETINE HYDROCHLORIDE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ERGOCALCIFEROL, LEVOCETIRIZINE DIHYDROCHLORIDE, |
||||
| 120 | 26931802 |
US |
2 | |
Skin irritation, Erythema, |
||||
PEGVALIASE-PQPZ, PEGVALIASE-PQPZ, FAMOTIDINE, CIMETIDINE, OMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, FAMOTIDINE 20MG, RANITIDINE HYDROCHLORIDE, ACYCLOVIR, CETIRIZINE HCL, CETIRIZINE HYDROCHLORIDE, AZELASTINE HYDROCHLORIDE, AZELASTINE, BUDESONIDE, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, EPINEPHRINE, INSULIN ASPART INJECTION, INSULIN ASPART, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, HYDROXYZINE HYDROCHLORIDE ORAL, MONTELUKAST SODIUM, MONTELUKAST, TIRZEPATIDE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, MONTELUKAST SODIUM, SPIRONOLACTONE, VALACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, |
||||
| 121 | 26932100 |
US |
2 | |
Skin texture abnormal, Erythema, Pruritus, |
||||
DUPILUMAB, |
||||
| 122 | 26932114 |
US |
1 | |
Weight increased, Gastrointestinal disorder, Pruritus, Peripheral swelling, Insomnia, Erythema, Product use in unapproved indication, Drug ineffective, |
||||
DUPILUMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, CLOPIDOGREL, CLOPIDOGREL BISULFATE, LISINOPRIL, PANTOPRAZOLE SODIUM, SUCRALFATE, SUCRALFATE ORAL SUSPENSION, SUCRALFATE ORAL, UBROGEPANT, VITAMIN E, CETIRIZINE HYDROCHLORIDE, |
||||
| 123 | 26932199 |
US |
74 | 1 |
Eczema, Pruritus, Skin lesion, Erythema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 124 | 26932342 |
US |
27 | 2 |
Erythema, Skin burning sensation, Pruritus, |
||||
CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, |
||||
| 125 | 26932359 |
EU |
66 | 2 |
Erythema, Oedema, Pyrexia, Eosinophilia, |
||||
AMOXICILLIN, DEXTROMETHORPHAN HYDROBROMIDE, |
||||
| 126 | 26932428 |
GB |
57 | 2 |
Neuropathy peripheral, Back pain, Rash, Constipation, Dry skin, Epistaxis, Mouth ulceration, Erythema, |
||||
PEMBROLIZUMAB, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, FILGRASTIM, FAMOTIDINE, |
||||
| 127 | 26932687 |
US |
63 | 2 |
Pruritus, Erythema, Condition aggravated, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 128 | 26932725 |
US |
||
Type IV hypersensitivity reaction, Erythema, Urticaria, |
||||
ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, OFATUMUMAB, LORATADINE, LORATADINE TABLET, |
||||
| 129 | 26932850 |
US |
61 | 2 |
Gait disturbance, Erythema, Skin burning sensation, Speech disorder, Product dose omission issue, Hypoaesthesia, |
||||
DIROXIMEL FUMARATE, DIROXIMEL FUMARATE, |
||||
| 130 | 26932893 |
|||
Erythema, |
||||
METOPROLOL TARTRATE, |
||||
| 131 | 26932947 |
|||
Feeling abnormal, Nasal congestion, Sinus congestion, Erythema, Wrong technique in product usage process, |
||||
METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, CLOPIDOGREL, |
||||
| 132 | 26933205 |
US |
2 | 2 |
Dermatitis atopic, Skin fissures, Erythema, Pruritus, Dry skin, |
||||
DUPILUMAB, |
||||
| 133 | 26933293 |
US |
2 | 1 |
Dry skin, Erythema, Skin fissures, Lip erythema, |
||||
DUPILUMAB, |
||||
| 134 | 26933419 |
US |
57 | 2 |
Dry eye, Erythema, |
||||
DUPILUMAB, |
||||
| 135 | 26933448 |
US |
36 | |
Skin tightness, Dry skin, Erythema, |
||||
DUPILUMAB, |
||||
| 136 | 26933508 |
US |
17 | 1 |
Erythema, |
||||
DUPILUMAB, |
||||
| 137 | 26933522 |
US |
58 | 1 |
Abdominal distension, Nausea, Arthropod sting, Swelling, Erythema, |
||||
DUPILUMAB, |
||||
| 138 | 26933689 |
US |
2 | |
Eczema, Erythema, Therapeutic response shortened, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 139 | 26933783 |
US |
20 | 2 |
Photosensitivity reaction, Rash, Erythema, Fatigue, Pyrexia, Chills, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 140 | 26938134 |
53 | 2 | |
Skin reaction, Erythema, Pruritus, Skin irritation, Skin exfoliation, Product label issue, Oedema, Rash, Hypersensitivity, Alopecia, Product odour abnormal, Eye pruritus, |
||||
| 141 | 26926796 |
52 | ||
Arthralgia, Urticaria, Pruritus, Erythema, |
||||
METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CLOPIDOGREL, |
||||
| 142 | 26926817 |
US |
2 | |
Erythema, Pruritus, Chest discomfort, Influenza like illness, |
||||
ZOLEDRONIC ACID, |
||||
| 143 | 26927255 |
US |
69 | 2 |
Urticaria, Pruritus, Skin lesion, Skin haemorrhage, Erythema, Contusion, Swelling face, Skin mass, Dilated pores, Burning sensation, Varicose vein, Heart rate increased, Sleep disorder due to a general medical condition, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, PREDNISONE, |
||||
| 144 | 26927264 |
US |
68 | 2 |
Dermatitis allergic, Erythema, Skin exfoliation, Dry eye, Visual acuity reduced, Visual impairment, |
||||
DUPILUMAB, |
||||
| 145 | 26927453 |
EU |
75 | 1 |
Cytopenia, Erythema, |
||||
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, POMALIDOMIDE, BORTEZOMIB, |
||||
| 146 | 26927515 |
US |
74 | 2 |
Swelling, Erythema, |
||||
DUPILUMAB, |
||||
| 147 | 26927607 |
US |
2 | |
Rash, Erythema, Pruritus, |
||||
OXYBUTYNIN, |
||||
| 148 | 26927818 |
EU |
83 | 1 |
Malaise, Hypoaesthesia, Erythema, Infusion related reaction, |
||||
ALFUZOSIN HYDROCHLORIDE, BISOPROLOL FUMARATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FUROSEMIDE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 149 | 26927948 |
CN |
37 | 2 |
Urticaria, Off label use, Erythema, Pruritus, |
||||
RITUXIMAB, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 150 | 26928348 |
RU |
73 | 2 |
Erythema, Pruritus genital, |
||||
DAPAGLIFLOZIN, |
||||
| 151 | 26928409 |
CA |
1 | 1 |
Pruritus, Erythema, |
||||
DUPILUMAB, MOMETASONE FUROATE, MOMETASONE, FLUOCINOLONE ACETONIDE, CICLESONIDE, |
||||
| 152 | 26928414 |
US |
30 | 2 |
Dermatitis atopic, Erythema, |
||||
DUPILUMAB, |
||||
| 153 | 26928451 |
US |
22 | 1 |
Erythema, Dry skin, Pruritus, Skin fissures, |
||||
DUPILUMAB, |
||||
| 154 | 26928508 |
CO |
38 | 2 |
Feeling hot, Erythema, Oedema peripheral, Pruritus, |
||||
IRON SUCROSE, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 155 | 26929002 |
US |
27 | 2 |
Rash, Hypersensitivity, Pruritus, Erythema, Hot flush, Abdominal pain upper, |
||||
BREMELANOTIDE, |
||||
| 156 | 26929236 |
US |
52 | 2 |
Swelling, Erythema, Skin exfoliation, Discharge, Skin hypopigmentation, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 157 | 26929434 |
US |
27 | 2 |
Injury associated with device, Paternal exposure during pregnancy, Injection site haemorrhage, Erythema, Peripheral swelling, Skin discolouration, |
||||
RISANKIZUMAB-RZAA, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 158 | 26929572 |
GB |
71 | 1 |
Joint swelling, Muscle spasms, Dizziness, Erythema, |
||||
AMLODIPINE, EZETIMIBE, |
||||
| 159 | 26929596 |
US |
2 | |
Erythema, |
||||
BRENSOCATIB, BRENSOCATIB, ALBUTEROL SULFATE, ALBUTEROL, ALENDRONATE SODIUM, ALENDRONATE SODIUM TABLET, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, BIOTIN, CHOLESTYRAMINE, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, FLUTICASONE PROPIONATE, LOSARTAN, MELOXICAM, MELATONIN, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 160 | 26929779 |
US |
2 | |
Erythema, Skin hypertrophy, Dry skin, |
||||
BRENSOCATIB, |
||||
| 161 | 26930031 |
US |
1 | |
Pain in extremity, Skin fissures, Erythema, Skin exfoliation, Dry skin, |
||||
BRENSOCATIB, ALBUTEROL SULFATE, ALBUTEROL, APIXABAN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ATORVASTATIN CALCIUM, CARVEDILOL, EMPAGLIFLOZIN, FAMOTIDINE, FUROSEMIDE, LOSARTAN POTASSIUM, MONTELUKAST SODIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SOTALOL HYDROCHLORIDE, TIOTROPIUM BROMIDE, SPIRONOLACTONE, |
||||
| 162 | 26930167 |
EU |
57 | 1 |
Pancreatitis, Erythema, |
||||
GEMCITABINE HYDROCHLORIDE, GEMCITABINE, OXALIPLATIN, METHOTREXATE, METHOTREXATE SODIUM, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, SULFAMETHOXAZOLE AND TRIMETHOPRIM, VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR, FILGRASTIM, PANTOPRAZOLE, TRAMADOL HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 163 | 26930358 |
US |
27 | 1 |
Erythema, Skin exfoliation, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 164 | 26930498 |
US |
||
Swelling face, Pruritus, Erythema, |
||||
INCOBOTULINUMTOXINA, |
||||
| 165 | 26930589 |
US |
2 | |
Pruritus, Paraesthesia, Burning sensation, Erythema, |
||||
OXYBUTYNIN, |
||||
| 166 | 26930660 |
57 | 1 | |
Sunburn, Erythema, |
||||
REPOSITORY CORTICOTROPIN, |
||||
| 167 | 26930689 |
CN |
80 | |
Erythema, Pruritus, |
||||
CEFTOBIPROLE MEDOCARIL SODIUM, DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
| 168 | 26930883 |
CA |
50 | 1 |
Erythema, Flushing, Nausea, Glomerulonephritis minimal lesion, Condition aggravated, Off label use, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, CYCLOSPORINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, METHYLPREDNISOLONE, |
||||
| 169 | 26921312 |
US |
70 | 2 |
Eye swelling, Eye irritation, Eye pruritus, Erythema, Swelling face, |
||||
TIMOLOL MALEATE, TIMOLOL MALEATE OPHTHALMIC, |
||||
| 170 | 26921418 |
EU |
21 | 1 |
Coagulation factor decreased, Liver function test increased, Alanine aminotransferase increased, Sleep disorder, Weight increased, Swelling face, Erythema, Fatigue, Coagulation factor decreased, Epstein-Barr virus test positive, Pyrexia, |
||||
BUDESONIDE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, ETRANACOGENE DEZAPARVOVEC, |
||||
| 171 | 26921558 |
US |
86 | 2 |
Burning sensation, Product adhesion issue, Erythema, |
||||
OXYBUTYNIN, CALCIUM, CEVIMELINE HYDROCHLORIDE, CEVIMELINE, FELODIPINE, FELODIPINE EXTENDED-RELEASE TABLETS, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, SIMVASTATIN, IRBESARTAN, |
||||
| 172 | 26921672 |
JP |
2 | |
Cataract, Rash, Injection site erythema, Injection site rash, Injection site pain, Injection site pruritus, Urticaria, Pruritus, Erythema, Inappropriate schedule of product administration, |
||||
INCLISIRAN, INCLISIRAN, |
||||
| 173 | 26921697 |
EU |
31 | 1 |
Erythema, Pain in extremity, |
||||
DUPILUMAB, |
||||
| 174 | 26921726 |
US |
1 | |
Swelling, Erythema, Pruritus, Product dispensing issue, |
||||
DUPILUMAB, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRALOKINUMAB-LDRM, DESONIDE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, |
||||
| 175 | 26921758 |
US |
2 | |
Night sweats, Influenza like illness, Erythema, Dyspnoea, Fatigue, |
||||
ZOLEDRONIC ACID, |
||||
| 176 | 26921847 |
EU |
2 | |
Heart rate increased, Poor quality sleep, Irritability, Fatigue, Brain fog, Anger, Erythema, Asthenia, Pruritus, Drug ineffective, Product adhesion issue, |
||||
ESTRADIOL, |
||||
| 177 | 26922003 |
JP |
63 | 1 |
Bladder tamponade, Erythema, Malignant neoplasm progression, Therapy partial responder, |
||||
PEMBROLIZUMAB, PEMBROLIZUMAB, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, |
||||
| 178 | 26922092 |
BR |
2 | |
Malaise, Urticaria, Feeding disorder, Pruritus, Nausea, Tongue discomfort, Tongue discolouration, Oedema, Skin plaque, Glossodynia, Plicated tongue, Oropharyngeal pain, Pruritus, Tumour marker increased, Dry mouth, Metastasis, Thrombosis, Bone loss, Immunodeficiency, Metastases to bone, Metastases to lung, Metastases to liver, Osteoporosis, Dry skin, Weight decreased, Wound, Tongue disorder, Oral contusion, Skin disorder, Tongue injury, Tongue injury, Pain of skin, Sensitive skin, Skin irritation, Swelling, Glossitis, Feeding disorder, Tongue disorder, Feeding disorder, Tongue injury, Glossodynia, Swelling, Neck pain, Hypersensitivity, Erythema, Memory impairment, Discomfort, Feeling abnormal, Spinal pain, Pain, Decreased activity, Pain of skin, Adverse drug reaction, Hair colour changes, Tongue injury, Eating disorder, Back pain, Alopecia, Rash macular, Decreased appetite, Liver disorder, Mass, Pain in extremity, Tachycardia, Rib fracture, Rib fracture, Oral contusion, Skin disorder, Arthralgia, Spinal pain, Myalgia, COVID-19, Abdominal pain, Asthenia, Influenza, Pyrexia, Cough, Dyspepsia, Gastrooesophageal reflux disease, Weight decreased, Carbohydrate antigen 125 increased, Yellow skin, Sleep disorder, Tongue erythema, Vomiting, Urticaria, Vomiting, Nausea, Fatigue, Nausea, Fatigue, Headache, Application site pain, Treatment failure, Drug ineffective, Product dose omission issue, Product use in unapproved indication, Product dose omission in error, |
||||
ANASTROZOLE, ANASTROZOLE TABLETS, FULVESTRANT, FULVESTRANT, FULVESTRANT, FULVESTRANT, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, LETROZOLE, LETROZOLE TABLETS, LETROZOLE, LETROZOLE TABLETS, DENOSUMAB, FULVESTRANT, |
||||
| 179 | 26922178 |
US |
37 | 2 |
Dry skin, Pruritus, Rash, Erythema, |
||||
DUPILUMAB, |
||||
| 180 | 26922359 |
GB |
45 | 2 |
Erythema, Medication error, |
||||
MOMETASONE, |
||||
| 181 | 26922612 |
CN |
72 | 1 |
Erythema, Dermatitis, |
||||
TICAGRELOR, |
||||
| 182 | 26923155 |
VN |
62 | 2 |
Erythema, Defaecation disorder, Pruritus, Dizziness, Hypotension, Nausea, Vomiting, |
||||
OXALIPLATIN, CAPECITABINE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXTROSE MONOHYDRATE, DEXTROSE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 183 | 26923181 |
BR |
2 | |
Drug intolerance, Immunodeficiency, Epistaxis, Loss of consciousness, Haemangioma rupture, Liver injury, Spinal cord disorder, Spinal cord injury, Metastases to spine, Metastases to bone, Metastasis, Metastases to bone, Metastases to liver, Immunodeficiency, Face injury, Skin exfoliation, Dry throat, Alopecia, Erythema, Dry skin, Vulvovaginal dryness, Vulvovaginal discomfort, Vulvovaginal burning sensation, Nasal dryness, Skin disorder, Pruritus, Neoplasm, Gait disturbance, Tumour marker increased, Reflux gastritis, Discouragement, Visual impairment, Greater trochanteric pain syndrome, Feeding disorder, Haemangioma, Disease progression, Weight decreased, Illness, Aphthous ulcer, Oral herpes, Swelling of eyelid, Sinusitis, Rhinitis, Rhinitis allergic, Eyelid sensory disorder, Vein disorder, Frostbite, Ocular hyperaemia, Haemorrhoids, Hair texture abnormal, Trichorrhexis, Eyelid ptosis, Rectocele, Gastrointestinal disorder, Hiatus hernia, Nasal pruritus, Dry eye, Head discomfort, PIK3CA-activated mutation, Swelling, Abdominal discomfort, Head injury, Nasal injury, Skin lesion, Wound, Injury, Oestrogen deficiency, Drug ineffective, Panic disorder, Nasal discomfort, Haematoma, Asthenopia, Hypermetropia, Astigmatism, Petechiae, Dyspnoea, Skeletal injury, Phlebitis, Oral pain, Nasal disorder, Eye swelling, Anosmia, Movement disorder, Pain, Vulvovaginal exfoliation, Chills, Paraesthesia, White blood cell count decreased, Neutrophil count decreased, Pyrexia, Fatigue, Constipation, Dry mouth, Application site bruise, Application site pain, Ear disorder, Urinary tract infection, Skin atrophy, Lip dry, Pain, Pain in extremity, Bone pain, Dysstasia, Application site swelling, Arthralgia, Insomnia, Malaise, Product availability issue, |
||||
FULVESTRANT, ANASTROZOLE, ANASTROZOLE TABLETS, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, FULVESTRANT, FULVESTRANT, FULVESTRANT, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, ERGOCALCIFEROL, ACONITUM NAPELLUS, BRYONIA ALBA, EUPATORIUM PERFOLIATUM, FERRUM PHOSPHORICUM, GELSEMIUM SEMPERVIRENS, KALI BICHROMICUM, KALI LODATUM, ZINCUM GLUCONICUM., DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL, ACONITUM NAPELLUS, ALLIUM CEPA, GELSEMIUM SEMP., ZINCUM GLUCONICUM, BAPTISIA TINCTORIA, ECHINACEA ANGUSTIFOLIA, EUPATORIUM PERFOLIATUM, LOMATIUM DISSECTUM, PUERARIA LOBATA, TRIFOLIUM PRATENSE, PHYTOLACCA DECANDRA, ALLIUM CEPA, ARSENICUM IODATUM, BARYTA CARBONICA, BROMIUM, CALCAREA CARBONICA, KALI MURIATICUM, LACHESIS MUTUS, MERCURIUS SOLUBILIS, SILICEA, ACETAMINOPHEN, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCL, |
||||
| 184 | 26923187 |
EU |
59 | 2 |
Dermatitis allergic, Somnolence, Dizziness, Erythema, Skin swelling, Rash, |
||||
VALPROIC ACID, PALIPERIDONE PALMITATE, LORAZEPAM, LORAZEPAM, |
||||
| 185 | 26923758 |
US |
34 | 2 |
Erythema, Dry skin, Pruritus, Therapeutic response decreased, |
||||
DUPILUMAB, |
||||
| 186 | 26923773 |
JP |
26 | 1 |
Anaphylactic reaction, Seizure, Asthma, Tremor, Erythema, Pruritus, Flushing, Body temperature increased, |
||||
DUPILUMAB, |
||||
| 187 | 26924485 |
US |
2 | |
Urine abnormality, Skin burning sensation, Urticaria, Hypertension, Erythema, |
||||
BRENSOCATIB, BRENSOCATIB, ALBUTEROL SULFATE, ALBUTEROL, CLONAZEPAM, FISH OIL, INCLISIRAN, LEVALBUTEROL, LEVALBUTEROL HYDROCHLORIDE, OMEPRAZOLE MAGNESIUM, DENOSUMAB, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, VITAMIN C, |
||||
| 188 | 26924491 |
30 | 2 | |
Hot flush, Erythema, Pruritus, Paraesthesia oral, Throat tightness, Dry mouth, Vomiting, |
||||
RIMEGEPANT SULFATE, ATENOLOL, CETIRIZINE HYDROCHLORIDE, |
||||
| 189 | 26924711 |
EU |
48 | 2 |
Suffocation feeling, Erythema, Dyspnoea, Rash erythematous, Rash, |
||||
DOCETAXEL, DOCETAXEL ANHYDROUS, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, |
||||
| 190 | 26924912 |
CA |
73 | 1 |
Dyspnoea, Cough, Thrombosis, Sputum increased, Skin warm, Peripheral swelling, Erythema, Sensitive skin, Skin induration, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, ALBUTEROL SULFATE, CICLESONIDE, PREDNISONE, |
||||
| 191 | 26925122 |
GB |
1 | 2 |
Rash macular, Erythema, |
||||
CLOTRIMAZOLE, DRS. CLOTRIMAZOLE, FAMILY WELLNESS CLOTRIMAZOLE, CLOTRIMAZOLE TOPICAL, CEPHALEXIN, |
||||
| 192 | 26925127 |
US |
1 | |
Erythema, Scab, Rash macular, |
||||
FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, |
||||
| 193 | 26925159 |
US |
||
Skin burning sensation, Product administered at inappropriate site, Intentional product use issue, Erythema, |
||||
DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, |
||||
| 194 | 26925389 |
US |
1 | |
Accidental exposure to product, Erythema, |
||||
DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, |
||||
| 195 | 26925754 |
US |
2 | |
Erythema, Thermal burn, Headache, Dry skin, Pruritus, |
||||
BIMEKIZUMAB, |
||||
| 196 | 26925772 |
2 | ||
Complication associated with device, Erythema, Leukaemia, |
||||
TRETINOIN, |
||||
| 197 | 26925782 |
ZA |
16 | 1 |
Arthralgia, Pain in extremity, Chest pain, Bone pain, Cough, Erythema, Swelling, |
||||
GADOTERATE MEGLUMINE, |
||||
| 198 | 26925828 |
EU |
75 | 1 |
Cytopenia, Erythema, |
||||
BORTEZOMIB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, POMALIDOMIDE, |
||||
| 199 | 26925941 |
EU |
50 | 2 |
Pruritus, Flushing, Papule, Erythema, |
||||
GADOTERATE MEGLUMINE, DALFAMPRIDINE, |
||||
| 200 | 26926081 |
EU |
67 | 2 |
Tachycardia, Mouth swelling, Swollen tongue, Erythema, |
||||
OLANZAPINE, LEVOTHYROXINE SODIUM, QUETIAPINE, VALPROATE SODIUM, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30